Adamiszak .2022 .Drug interactions in COVID-19 treatment. Systematic review. J Farm Pol, 78(7) : 390-402.
Al-Azzam ,Barbara R Conway and Mamoon A Aldeyab .2021 .An assessment of the impact of coronavirus disease (COVID-19) pandemic on national antimicrobial consumption in Jordan. Antibiot, 10(6) : 690.
Ayerbe ,Salma Ayis .2022 .Azithromycin in patients with COVID-19: a systematic review and metaanalysis. J. Antimicrob. Chemother, 77(2) : 303-309.
Barnes ,Geoffrey D,Allison Burnett,Stacy Ellsworth Burnett,David Garcia Burnett .2020 .Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: Interim clinical guidance from the anticoagulation forum. J. Thromb. Thrombolysis, 50 : 72-81.
Cantudo-Cuenca MD,Ramon MorilloVerdugo MD .2021 .Drug-drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain. Sci. Rep, 11(1) : 1241-4.
Chen ,Yang Qiu,Jingli Wang,Wei Wang .2020 .Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, 395(10223) : 507-513.
Conti ,Raschi .2022 .Identification of drug interaction adverse events in patients with COVID-19: A systematic review. JAMA, 5(4) : e227970-e227970.
Doan Ramatou,Maliki Ramatou,Lebas Ramatou .2020 ."Macrolide and nonmacrolide resistance with mass azithromycin distribution. NEJM, 383(20) : 1941-1950.
Dorgalaleh ,Akbar .2020 .Bleeding and bleeding risk in COVID-19. , 46(7) : 815-818.
Gautret ,Jean-Christophe Lagier,Piseth Seng Lagier .2020 .Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis, 34 : 101663.
Hodge Saye,Khoo Saye,Antimicrob Saye .2020 .Drug interactions: A review of the unseen danger of experimental COVID-19 therapies. , 75(12) : 3417-3424.
Iloanusi Ekere J Essien. .2021 .Polypharmacy among COVID-19 patients: A systematic review. JAPhA., 61(5) : e14-e25.
Kim ,Tae-Ho Hwang .2020 .Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network metaanalysis. PLoS Med, 17(12) : e1003501.
Kournoutou Georgia G,George Dinos Georgia G .2022 .Azithromycin through the Lens of the COVID-19 Treatment. , 11(8) : 1063.
Li T,Higgins JPT,Deeks JJ,J Higgins JPT,Chandler J,Cumpston M,Li T,Page MJ,Welch VA .2021 .Collecting data. In Cochrane Handbook for Systematic Reviews of Interventions, 23 : 109-141.
Manjhi .2021 .Drug-drug interactions in patients with COVID-19: A retrospective study at a tertiary care Hospital in Eastern India. Maedica, 16(2) : 163.
Medscape .2023 .. , : .
Pourhoseingholi ,Rahimzadeh .2013 .Sample size calculation in medical studies. GHFBB, 6(1) : 14.
Rosenberg ,Eli S,Elizabeth M Dufort,Udo Tomoko,Jack DeHovitz Tomoko .2020 .Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-. , 323(24) : 2493-2502.
Soherwardi Bharti,Chogtu P,Faizal P .2012 .Surveillance of the potential drug-drug interactions in the medicine department of a tertiary care Hospital. JCDR., 6(7) : 1258-61.
Epidemiology Team .2020 .The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-. , 2(8) : 113-122.
Thomas ,Mari R,Marie Scully R,Hematol Am. J. .2022 .Clinical features of thrombosis and bleeding in COVID-19.. , 140(3) : 184-195.
Mustafa Ul .2021 .Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan. Chia Siang Kow and Syed Shahzad Hasan, 3(8) : 1691-1695.
Zequn ,Jiangfang .2021 .Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. Eur. J., : .
. .. , 893 : 173813.